ArticleBMJ nutrition, prevention & health2026
User experience and feasibility of CVD risk models: a study on clinician and patient expectations, and implementation in primary healthcare with P-CARDIAC pilot study in Hong Kong.
Article in BMJ nutrition, prevention & health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: A newly developed machine-learning-driven cardiovascular disease (CVD) risk prediction tool, the Personalised CARdiovascular DIsease risk Assessment for Chinese (P-CARDIAC), tailored for the Hong Kong population, has demonstrated superior predictive performance compared with existing risk prediction tool. This study aims to explore the acceptability and expectations of P-CARDIAC among clinicians and the general public, and to assess its feasibility within pharmacist-led services in local primary healthcare systems. Methods: A cross-sectional study was conducted to investigate the awareness and expectations of risk prediction tools among clinicians and the general public. A pragmatic pilot study was carried out to implement P-CARDIAC in pharmacist-led services at local primary healthcare centres. Data analysis included descriptive statistics, univariate regression modelling and reliability assessments of validated measurement scales. Results: For the cross-sectional study, a total of 113 of the general public and 17 clinicians responded to the questionnaire. The general public demonstrated low awareness but high health-seeking behaviour related to CVD risk prediction tools. Clinicians, especially cardiologists, reported limited experience with such tools due to unavailability and limited user-friendliness. In the pilot study, 15 participants engaged with pharmacist-led services incorporating P-CARDIAC. They expressed positive perceptions of the tool, believing that it could support better medication adherence and disease management. The pharmacist-led services incorporating P-CARDIAC were well-received by participants. Conclusion: P-CARDIAC demonstrates promise as a local risk prediction tool to enhance cardiovascular care in Hong Kong. The study underscores the importance of improving awareness and adoption of such CVD risk tools.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.